Literature DB >> 1675487

Molecular biology of prion diseases.

S B Prusiner1.   

Abstract

Prions cause transmissible and genetic neurodegenerative diseases, including scrapie and bovine spongiform encephalopathy of animals and Creutzfeldt-Jakob and Gerstmann-Sträussler-Scheinker diseases of humans. Infectious prion particles are composed largely, if not entirely, of an abnormal isoform of the prion protein, which is encoded by a chromosomal gene. A posttranslational process, as yet unidentified, converts the cellular prion protein into an abnormal isoform. Scrapie incubation times, neuropathology, and prion synthesis in transgenic mice are controlled by the prion protein gene. Point mutations in the prion protein genes of animals and humans are genetically linked to development of neuro-degeneration. Transgenic mice expressing mutant prion proteins spontaneously develop neurologic dysfunction and spongiform neuropathology. Understanding prion diseases may advance investigations of other neurodegenerative disorders and of the processes by which neurons differentiate, function for decades, and then grow senescent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675487     DOI: 10.1126/science.1675487

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  497 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Folding funnels, binding funnels, and protein function.

Authors:  C J Tsai; S Kumar; B Ma; R Nussinov
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

3.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

4.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance.

Authors:  D R Brown; F Hafiz; L L Glasssmith; B S Wong; I M Jones; C Clive; S J Haswell
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

6.  Normal prion protein has an activity like that of superoxide dismutase.

Authors:  D R Brown; B S Wong; F Hafiz; C Clive; S J Haswell; I M Jones
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

7.  Environmentally induced reversible conformational switching in the yeast cell adhesion protein alpha-agglutinin.

Authors:  H Zhao; M H Chen; Z M Shen; P C Kahn; P N Lipke
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

8.  Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; I Zaitsev; P Koni; Z Y Lu; R A Flavell; W Fritch
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Research on familial Creutzfeldt-Jakob disease (FCJD) resulting in presymptomatic testing: implications for the Human Genome Project.

Authors:  Janet E Ulm; Cindy L Vnencak-Jones; Patrick Bosque
Journal:  J Genet Couns       Date:  1993-03       Impact factor: 2.537

10.  One O-linked sugar can affect the coil-to-beta structural transition of the prion peptide.

Authors:  Pei-Yeh Chen; Chun-Cheng Lin; Yin-Ting Chang; Su-Ching Lin; Sunney I Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.